Inari Medical, Inc.

NASDAQ:NARI

44.38 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -31.348-24.202-4.6673.1622.085-2.218-5.798-10.153-10.187-3.1291.107-2.8044.0687.4696.9856.496-3.8044.1120.3550.366-0.965-0.948
Depreciation & Amortization 4.7374.6162.162.1722.142.9731.891.7441.8181.6671.66310.8590.7860.4540.3580.2990.2740.230.1560.1160.112
Deferred Income Tax 00-0.584-2.271-4.326000000.0690-0.1610.1390.2220.5792.9680.4330.7220.3240.1220.128
Stock Based Compensation 13.03912.879.8019.84410.35310.3397.5967.3567.1646.5554.50912.4994.6043.8361.5650.9590.5050.4950.1760.1390.0990.091
Change In Working Capital 19.024-11.3529.5423.022-0.504-9.4227.066-12.347-1.879-14.3087.624-16.316-2.108-3.5-10.889-3.08-1.154-6.046-2.34-1.343-1.54-1.036
Accounts Receivables -3.647-8.6720.512-7.005-7.3882.827-4.81-5.26-4.265-2.695-3.463-7.428-0.033-3.437-7.156-5.376-0.811-3.363-3.244-2.139-2.439-1.133
Change In Inventory -4.831-2.090.359-1.463-2.509-3.825-2.982-3.03-2.888-2.788-1.564-1.401-4.45-3.073-3.402-1.575-0.434-1.233-0.832-0.96-0.721-0.361
Change In Accounts Payables 4.3571.493-2.0922.853-0.1-0.3171.5811.319-1.293-0.4671.472-5.2344.8032.473-0.4861.239-0.570.3150.8250.8630.178-0.031
Other Working Capital 23.145-2.08310.7638.6379.4931.31513.277-5.3766.567-8.35811.179-2.253-2.4280.5370.1552.6320.661-1.7650.9110.8931.4410.49
Other Non Cash Items 32.6956.325-4.0110.010.012-3.6850.5010.3340.0230.1150.0350.0320.040.0360.0390.0290.0590.0540.0320.0230.0230.023
Operating Cash Flow 11.513-12.28812.24115.9399.76-2.01311.255-13.066-3.061-9.115.007-5.5897.3028.766-1.6245.341-1.126-0.679-0.826-0.335-2.144-1.631
Investing Activities:
Investments In Property Plant And Equipment -4.58-1.91-2.4-1.608-1.229-0.964-1.778-2.309-3.119-2.745-2.718-4.741-4.921-1.265-2.384-1.658-0.809-0.609-1.082-1.163-0.561-0.338
Acquisitions Net 3.7220-240.419-13.4294.8513.07931.469-15.71198.74105000000000000
Purchases Of Investments -17.537-21.501-11.677-110.331-162.351-122.379-160.069-101.289-118.741-117.766-28.939-20.687-63.505-21.246-49.9770000000
Sales Maturities Of Investments 12.63462.573194.78123.76157.5119.3128.61172047291850000000000
Other Investing Activites 3.722-0.66181.61213.429-4.851-3.079-31.46915.711-98.741-70.766-50-2.68750-21.246-49.9770000000
Investing Cash Flow -5.76139.162-59.71611.821-6.08-4.043-33.24713.402-101.86-73.511-2.657-7.428-18.426-22.511-52.361-1.658-0.809-0.609-1.082-1.163-0.561-0.338
Financing Activities:
Debt Repayment 000000-2.9690000000-0.07200-10-10.14000
Common Stock Issued 0.0983.9830.2785.8550.2144.3980.2015.1040.156178.1660.1373.8350.1922.263164.3610000000
Common Stock Repurchased -2.8513.983-2.688-2.388-2.566-1.932-1.89-1.224-1.751-1.624-0.757-0.842-0.706-0.049-0.0250000000
Dividends Paid 0000000000000000000000
Other Financing Activities -2.851-3.1130.2785.8550.2144.3980.2015.1040.156178.1660.1373.8350.1922.263-164.063-30.531164.39810.02220.1660.1780.0090.011
Financing Cash Flow -2.7531.015-2.413.467-2.3522.466-1.6893.88-1.595176.542-0.622.993-0.5142.2140.226-30.531164.39810.02210.0260.1780.0090.011
Other Information:
Effect Of Forex Changes On Cash -0.0140.11-0.0890.118-0.053-0.070.375-0.412-0.316-0.127-0.136-0.140.057-0.18300-00-0000
Net Change In Cash 2.98527.999-49.97431.3451.275-3.66-23.3063.804-106.83293.80411.594-10.164-11.581-11.714-53.759-26.848162.4638.7348.117-1.32-2.696-1.958
Cash At End Of Period 70.19267.20739.20889.18257.83756.56260.22283.52879.724186.55692.75281.15891.322102.903114.617168.376195.22432.76124.02715.9117.2319.926